WHO halts Hydroxychloroquine trial for treating COVID-19 patients

A per the statement by WHO, the data from the studies have shown that hydroxychloroquine does not result in the reduction of mortality of hospitalized COVID-19 patients.

Created On: Jun 18, 2020 15:03 IST
WHO halts HCQ trial
WHO halts HCQ trial

The World Health Organization (WHO) announced on June 17 that the testing of malaria drug hydroxychloroquine in its large multi-country trial for finding the treatment of COVID-19 has been halted after the new data shows no benefits on the patients.

Ana Maria Henao-Restrepo, WHO expert mentioned that the investigators leading the Solidarity Trial had reviewed the recent evidence and had decided to stop recruiting the new patients.

While addressing the media briefing, the WHO expert stated clearly that after deliberation, the investigators have concluded that the Hydroxychloroquine arm will be stopped from the solidarity trial.

The news was also shared on the official twitter account of WHO in which it has been mentioned that the trial is stopped as there is no evidence that HCQ reduces the mortality of hospitalised patients.

WHO statement on halting HCQ trial:

The World Health Organization (WHO) on June 17 released a statement mentioning that the decision was based on the evidence from the solidarity Trial as well as from the United Kingdom (UK)-led trial. Both of them have found that the drug does not help COVID-19 patients. There was also another review of other evidence on Hydroxychloroquine which led to this decision.

The statement added that the data from the studies have shown that hydroxychloroquine does not result in the reduction of mortality of the COVID-19 patients who are hospitalized. The statement further cleared that the Solidarity Trial investigators will not add any more patients to the HCQ arm.

However, the statement by WHO informed that the patients who had already started with HCQ but have not yet finished their course in the trial can complete their course or stop at the discretion of the supervising physician.

Halting of HCQ trial in the UK and US:

As per the data from the UK led trial which is known as Recovery Trial informed last week that the anti-malarial drug had shown no benefit for the COVID-19 patients.

The United States Food and Drug Administration on June 15 had revoked its emergency use authorization for hydroxychloroquine for the treatment of COVID-19 patients. The agency mentioned that it was no longer reasonable to believe that Hydroxychloroquine as well as the related drug chloroquine has been effective in treating the virus.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

AndroidIOS

Related Stories

Comment (0)

Post Comment

3 + 4 =
Post
Disclaimer: Comments will be moderated by Jagranjosh editorial team. Comments that are abusive, personal, incendiary or irrelevant will not be published. Please use a genuine email ID and provide your name, to avoid rejection.

    Monthly Current Affairs PDF

    • Current Affairs PDF October 2021
    • Current Affairs PDF September 2021
    • Current Affairs PDF August 2021
    • Current Affairs PDF July 2021
    • Current Affairs PDF June 2021
    • Current Affairs PDF May 2021
    • Current Affairs PDF April 2021
    • Current Affairs PDF March 2021
    View all

    Monthly Current Affairs Quiz PDF

    • Current Affairs Quiz PDF October 2021
    • Current Affairs Quiz PDF September 2021
    • Current Affairs Quiz PDF August 2021
    • Current Affairs Quiz PDF July 2021
    • Current Affairs Quiz PDF June 2021
    • Current Affairs Quiz PDF May 2021
    • Current Affairs Quiz PDF April 2021
    • Current Affairs Quiz PDF March 2021
    View all